These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 25913725)

  • 1. Chemical approach for target-selective degradation of oligosaccharides using photoactivatable organic molecules.
    Toshima K; Takahashi D
    Glycoconj J; 2015 Oct; 32(7):475-82. PubMed ID: 25913725
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chemical methods for degradation of target oligosaccharides using designed light-activatable organic molecules.
    Takahashi D; Toshima K
    Chem Commun (Camb); 2012 May; 48(37):4397-407. PubMed ID: 22378294
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Degradation of target oligosaccharides by anthraquinone-lectin hybrids with light switching.
    Imai Y; Hirono S; Matsuba H; Suzuki T; Kobayashi Y; Kawagishi H; Takahashi D; Toshima K
    Chem Asian J; 2012 Jan; 7(1):97-104. PubMed ID: 21997955
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Photodegradation of target oligosaccharides by light-activated small molecules.
    Takahashi D; Hirono S; Hayashi C; Igarashi M; Nishimura Y; Toshima K
    Angew Chem Int Ed Engl; 2010 Dec; 49(52):10096-100. PubMed ID: 21110364
    [No Abstract]   [Full Text] [Related]  

  • 5. Photodegradation of lipopolysaccharides and the inhibition of macrophage activation by anthraquinone-boronic acid hybrids.
    Takahashi D; Miura T; Toshima K
    Chem Commun (Camb); 2012 Aug; 48(61):7595-7. PubMed ID: 22733145
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Target-selective degradation of proteins and oligosaccharides by light-activated hybrid molecules for molecular-targeted photodynamic therapy.
    Toshima K
    Future Med Chem; 2009 Sep; 1(6):1113-24. PubMed ID: 21425996
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Carbohydrate recognition and photodegradation by an anthracene-Kemp's acid hybrid.
    Nishibu M; Takahashi D; Toshima K
    Org Biomol Chem; 2012 Nov; 10(42):8393-5. PubMed ID: 23026910
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chemical biology based on target-selective degradation of proteins and carbohydrates using light-activatable organic molecules.
    Toshima K
    Mol Biosyst; 2013 May; 9(5):834-54. PubMed ID: 23247895
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Target-selective photodegradation of oligosaccharides by a fullerene-boronic acid hybrid upon visible light irradiation.
    Takahashi D; Hirono S; Toshima K
    Chem Commun (Camb); 2011 Nov; 47(42):11712-4. PubMed ID: 21952514
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A fluorescent bisboronic acid compound that selectively labels cells expressing oligosaccharide Lewis X.
    Gao X; Zhu M; Fan H; Yang W; Ni W; Karnati VV; Gao S; Carson J; Weston B; Wang B
    Bioorg Med Chem Lett; 2015 Jun; 25(12):2501-4. PubMed ID: 25956415
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Target-selective photo-degradation of AFP-L3 and selective photo-cytotoxicity against HuH-7 hepatocarcinoma cells using an anthraquinone-PhoSL hybrid.
    Okuyama M; Ueno H; Kobayashi Y; Kawagishi H; Takahashi D; Toshima K
    Chem Commun (Camb); 2016 Feb; 52(10):2169-72. PubMed ID: 26698630
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Target-selective degradation of oligosaccharides by a light-activated small-molecule-lectin hybrid.
    Ishii M; Matsumura S; Toshima K
    Angew Chem Int Ed Engl; 2007; 46(44):8396-9. PubMed ID: 17899623
    [No Abstract]   [Full Text] [Related]  

  • 13. Triazole-linked fluorescent bisboronic acid capable of selective recognition of the Lewis Y antigen.
    Wang Y; Rong R; Chen H; Zhu M; Wang B; Li X
    Bioorg Med Chem Lett; 2017 May; 27(9):1983-1988. PubMed ID: 28351593
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of an Anthracene Intermediate in Dynemicin Biosynthesis.
    Cohen DR; Townsend CA
    Angew Chem Int Ed Engl; 2018 May; 57(20):5650-5654. PubMed ID: 29512267
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 9-Nitroanthracene derivative as a precursor of anthraquinone for photodynamic therapy.
    Fukuhara K; Oikawa S; Hakoda N; Sakai Y; Hiraku Y; Shoda T; Saito S; Miyata N; Kawanishi S; Okuda H
    Bioorg Med Chem; 2007 Jun; 15(11):3869-73. PubMed ID: 17400461
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Benzoboroxoles as efficient glycopyranoside-binding agents in physiological conditions: structure and selectivity of complex formation.
    Bérubé M; Dowlut M; Hall DG
    J Org Chem; 2008 Sep; 73(17):6471-9. PubMed ID: 18549270
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immobilization of glycoconjugates by their oligosaccharides: use of hydrazido-derivatized matrices.
    O'Shannessy DJ; Wilchek M
    Anal Biochem; 1990 Nov; 191(1):1-8. PubMed ID: 2127657
    [No Abstract]   [Full Text] [Related]  

  • 18. Microbial metabolism of 1-aminoanthracene by Beauveria bassiana.
    Zhan J; Gunatilaka AA
    Bioorg Med Chem; 2008 May; 16(9):5085-9. PubMed ID: 18378148
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Carbohydrate-modulated DNA photocleavage: design, synthesis, and evaluation of novel glycosyl anthraquinones.
    Toshima K; Maeda Y; Ouchi H; Asai A; Matsumura S
    Bioorg Med Chem Lett; 2000 Oct; 10(19):2163-5. PubMed ID: 11012020
    [TBL] [Abstract][Full Text] [Related]  

  • 20. G-quadruplex DNA: a target for drug design.
    Mergny JL; Hélène C
    Nat Med; 1998 Dec; 4(12):1366-7. PubMed ID: 9846570
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.